Biopharmaceuticals
HIV/AIDS
FDA
News Release - December 21, 2007
Supplemental New Drug Application for PREZISTA(TM) Submitted to U.S. Food and Drug Administration
Source: Tibotec
Issuer of this News Release is solely responsible for its
content.
Please address inquiries directly to the issuing company.